Dialysis and blood filtering

Every manufacturer places this the same way.

scroll for all 10 products →

Which section of each manufacturer's label carries this concept
Section	Neon Healthcare Ltd2mg Tablets	Neon Healthcare Ltd4mg Tablets	Neon Healthcare Ltd8mg Tablets	Sandoz Limited4mg Tablets	Viatris (formerly Mylan or Upjohn)4mg Tablets	Aurobindo Pharma - Milpharm Ltd.32mg Tablets	Krka UK Ltd4mg Tablets	Aurobindo Pharma - Milpharm Ltd.4mg Tablets	Krka UK Ltd8mg Tablets	Aurobindo Pharma - Milpharm Ltd.8mg Tablets
ContraindicatedThe label says it must not be used.
WarningThe label says it can be used, with care.	Warning	Warning	Warning	Warning	Warning	Warning	Warning	Warning	Warning	Warning
InteractionThe label says another medicine affects it.
PregnancyThe label gives advice for pregnancy or breastfeeding.
ExcipientThe label lists it as an ingredient, not a restriction.

Warning
- Neon Healthcare Ltd
  2mg Tablets · revised 17/01/2025
  2614–2627 of 7785 characters
  Source SmPC ↗
- Neon Healthcare Ltd
  4mg Tablets · revised 17/01/2025
  2613–2626 of 7784 characters
  Source SmPC ↗
- Neon Healthcare Ltd
  8mg Tablets · revised 17/01/2025
  2613–2626 of 7781 characters
  Source SmPC ↗
- Sandoz Limited
  4mg Tablets · revised 13/06/2022
  2493–2506 of 7739 characters
  Source SmPC ↗
- Viatris (formerly Mylan or Upjohn)
  4mg Tablets · revision unknown
  2615–2628 of 7816 characters
  Source SmPC ↗
- Aurobindo Pharma - Milpharm Ltd.
  32mg Tablets · revised 28/05/2026
  1765–1778 of 7908 characters
  Source SmPC ↗
- Krka UK Ltd
  4mg Tablets · revised 19/11/2020
  1682–1695 of 7572 characters
  Source SmPC ↗
- Aurobindo Pharma - Milpharm Ltd.
  4mg Tablets · revised 28/05/2026
  1765–1778 of 7908 characters
  Source SmPC ↗
- Krka UK Ltd
  8mg Tablets · revised 16/11/2020
  1638–1651 of 7529 characters
  Source SmPC ↗
- Aurobindo Pharma - Milpharm Ltd.
  8mg Tablets · revised 28/05/2026
  1765–1778 of 7908 characters
  Source SmPC ↗
nt close monitoring of renal function, electrolytes and blood pressure. ACE-inhibitors and angiotensin II receptor blockers should not be used concomitantly in patients with diabetic nephropathy. Haemodialysis During dialysis the blood pressure may be particularly sensitive to AT1-receptor blockade as a result of reduced plasma volume and activation of the renin-angiotensin-aldosterone system. Therefore
Identical in all 10 labels. Surrounding text shown from Neon Healthcare Ltd.